Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorUniversity Health Network, Toronto
About this trial
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Eligibility criteria
Qualifiers
Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study
Disqualifiers
Concomitant use of illicit drugs
Concomitant use of recreational cannabis
Trial design
Treatments tested in this trial
- Medical Cannabis
Treatment groups
No treatment groups listed
Sponsors and collaborators
University Health Network, Toronto
Lead sponsor
Avicanna Inc
Collaborator
Source ClinicalTrials.gov